PGI25 Cost-Utility Analysis of Telaprevir in Combination With Peginterferon Alpha and Ribavirin in Previously Treated Patients With Chronic Hepatitis C
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.774
https://www.valueinhealthjournal.com/article/S1098-3015(12)02487-4/fulltext
Title :
PGI25 Cost-Utility Analysis of Telaprevir in Combination With Peginterferon Alpha and Ribavirin in Previously Treated Patients With Chronic Hepatitis C
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02487-4&doi=10.1016/j.jval.2012.08.774
First page :
A330
Section Title :
Gastrointestinal Disorders
Open access? :
No
Section Order :
285